Syensqo, the specialty chemicals company to emerge from Solvay's demerger in December, unveils its growth strategy for the next five years 'aimed at creating significant value', as well as its medium-term financial targets.

On an organic basis, it is targeting net sales growth of between 5 and 7% over the period 2024-28, as well as, in percentage terms and by 2028, an underlying EBITDA margin in the mid-twenties and a ROCE in the mid-teens.

Achieving these targets should enable it to generate over seven billion euros in cash between 2024 and 2028. Syensqo intends to give priority to growth 'while maintaining a solid investment grade financial rating'.

Copyright (c) 2023 CercleFinance.com. All rights reserved.